Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.3.5 (
5'-nucleotidase
)
3,167
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The present state of investigations on molecular and cellular mechanisms of cardioprotective effects of phosphocreatine (PCr) is reviewed. The protective effect of PCr is manifested as significant improvement of heart contractile function recovery, lowering of diastolic pressure elevation and myocardial enzymes release during postischemic reperfusion as well as better preservation of high energy phosphates in comparison with control. Data from multidisciplinary studies using physico-chemical, physiological, pharmacological etc. approaches suggest that one of the key mechanisms of PCr action is its interaction with the sarcolemmal membrane. The authors own data obtained with the use of spin-labeled
ESR
-probe incorporated into the isolated sarcolemmal vesicles provide direct evidence in favor of the ordering effect of PCr sarcolemmal phospholipid packing with essential involvement of Ca2+ ions. PCr transform membrane phospholipids into more structured gel-like state. The results of biomedical studies suggest that the mechanism of this protective action is complex and includes at least four components: 1) inhibition of lysophosphoglyceride accumulation in the ischemic myocardium and preservation of cardiac cell sarcolemma structure via zwitterionic interaction with PCr molecules; ii) extracellular action consisting in inhibition of platelet aggregation via ADP removal in the extracellular creatine kinase reaction and increasing plasticity of red blood cells; iii) PCr penetration into cells maintenance of high local ATP levels is possible; iiii) inhibition of adenine nucleotide degradation at the step of
5'-nucleotidase
reaction in cardiac cell sarcolemma.
...
PMID:[Molecular and cellular aspects of the cardioprotective mechanism of phosphocreatine]. 129 51
In bull seminal plasma
5'-nucleotidase
is present in heterogeneous forms. The heterogeneity is abolished by treatment of bull seminal plasma with the detergent sodium cholate. The purified enzyme, which is a glycoprotein, shows an apparent molecular mass of 160 kDa on gel filtration in the presence of 50 mmol sodium cholate and an apparent molecular mass of 72 kDa upon SDS/polyacrylamide-gel electrophoresis. The
5'-nucleotidase
of bull seminal plasma is a metalloprotein containing 2 zinc ions per molecule of dimeric protein. The removal of the two zinc ions from the protein results in a completely inactive apoenzyme. The substitution of the endogenous zinc with Co(II) Cu(II) produces a holoenzyme which is slightly activated in the case of Co(II), whereas, in the case of Cu(II) only 65% of the initial activity is recovered. The enzyme has a covalently attached glycosyl-phosphatidylinositol moiety which can be removed by treatment with phosphatidylinositol-specific phospholipase C.
ESR
studies have indicated a radius of 35 A for the protein and that Cu(II) binds to the metal-free enzyme to a site in which sulphur donors can be excluded.
...
PMID:5'-Nucleotidase from bull seminal plasma. Biochemical and biophysical aspects. 196 12
5'-Nucleotidase of bull seminal plasma has been spin labeled with the sulfhydryl reagent 3-maleimidoproxyl.
ESR
analysis reveals the presence of two classes of labeled sites. The first is characterized by a long spin label rotational correlation time, from which a protein diameter of about 70 A can be estimated, under the assumption of a spherical shape. The second class is characterized by a shorter correlation time of the covalently bound spin labels and binding of the substrate sodium thymidine 5'-monophosphate to
5'-nucleotidase
results in a reduction of their mobility. Low-temperature
ESR
analysis shows that no paramagnetic ion is bound to the native protein.
...
PMID:ESR study of 5'-nucleotidase from bull seminal plasma. 283 45